A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Summary

This is a single-arm, multi-center, open-label, Phase 2 study to determine the efficacy and safety of JCAR015 in adult subjects with B-cell ALL. The study is divided into two sequential parts, Part A and Part B; subjects will be screened and will provide informed consent before initiating any study procedures in Part A of the study.

Timeline

Start

2016-12-20

Primary completion

2019-06-25

Completion

2021-01-24

Outcome

Outcome not reported

Stopped (Enrollment): “Development of JCAR015 has been discontinued. No subjects were enrolled/treated under protocol JCAR015-ALL-001”

Drugs

Indications